Hematopoietic stem cell therapy for malignant diseases

Author： Shapira Michael   Hai Ali Abdul   Tsirigotis Panagiotis   Resnick Igor   Or Reuven   Slavin Shimon  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.39, Iss.6, 2007-01, pp. : 465-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

Unrelated donor hematopoietic stem cell transplantation for the treatment of non‐malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1021-1026

John Wiley & Sons Inc

Access to resources Recommend Favorite

Principles of alemtuzumab immunoablation in hematopoietic cell transplantation for non‐malignant diseases in children: A review

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radiologic resolution of malignant infantile osteopetrosis skeletal changes following hematopoietic stem cell transplantation

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1645-1649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 422-427

John Wiley & Sons Inc

Access to resources Recommend Favorite